Replacing Dietary Fish Oil with Vegetable Oil Blends in Female Rainbow Trout Brood Stock Does Not Affect Breeding Quality.

To determine the effects of replacing fish oil (FO) with a mixture of vegetable oils (VO) in plant protein-rich diets on reproductive performance, the fatty acid profile of embryos as well as health indices of female rainbow trout (Oncorhynchus mykiss) brooders (initial mean body weight, 1.8 ± 0.1 kg), a 3-month feeding trial was conducted. Four isoproteic (ca. 42%) and isoenergetic (ca. 20 MJ/kg) diets were formulated in which 50% (FO50/VO50), 75% (FO25/VO75), and 100% (VO100) of FO were replaced by a mixture of VO, whereas the control diet (FO100) was prepared with FO as the major source of lipid. Fish fed the VO100 had the lowest fertilization (73.0 ± 2.5%), survival at eyed-embryo stage (62.5 ± 5.0%), and hatching rate (56.0 ± 4.7%) rates. Brood fish fed the FO50/VO50, FO25/VO50, and VO100 diets had higher levels of saturated and monounsaturated fatty acids in embryos in comparison with fish fed FO100 diet. The levels of docosahexaenoic acid of embryos gradually decreased during embryogenesis in all treatments, whereas the concentrations of eicosapentaenoic acid was greatly increased at hatching day (35 days after spawning). Regarding serum biochemical parameters, fish fed the VO100 diet had the highest serum glucose, cholesterol, and low-density lipoprotein levels. The results of the current study revealed that replacement of dietary FO with a mixture of VO up to 75% did not have any adverse effects on reproductive performance and health indices of O. mykiss females.

Dietary antioxidative supplements and diabetic retinopathy; a systematic review.

PURPOSE: There is controversial data regarding the effects of dietary antioxidative supplements on diabetic retinopathy (DR). We conducted a systematic review of both observational and randomized controlled clinical trials (RCTs) to clarify whether they are effective or not. METHODS: All observational and RCTs conducted by antioxidative supplements on DR published up to 1 January 2018 in PubMed, Web of Sciences, Scopus and Cochrane Library databases were included. Exclusion criteria were animal studies, and studies conducted in Type 1 diabetes mellitus (T1DM), children or pregnant women. Main outcome measures were reporting the incidence or progression of DR in T2DM by assessment of visual fields, and measurements of oxidative and antioxidative biomarkers. The quality of reporting of included articles and risk of bias were assessed. RESULTS: Finally, we reached 14 observational studies and 7 RCTs that conducted on 256,259 subjects. Due to severe methodological heterogeneity, only qualitative synthesis was carried. All studies were reported a significantly lower level of antioxidants and higher level of oxidative stress biomarkers in DR compared with others. There was an inverse significant correlation between vitamin C and malondialdehyde (MDA) (r = -0.81) or DNA damage (r = -0.41). These figures were statistically significant between vitamin E and MDA (r = 0.77) or superoxide dismutase (r = 0.44). Coefficient of correlation between MDA and zinc (-0.82), coenzyme Q10 (0.56), and magnesium (-0.73) was significant. Multi-oxidants trials were shown non-significant beneficial effects on DR. CONCLUSIONS: Although our study supports the positive effects of antioxidative supplements on DR, more high quality studies are needed to confirm.

Improvement of hypertrophic scarring by using topical anti-fibrogenic/anti-inflammatory factors in a rabbit ear model.

This study investigates the scar-reducing efficacy of topical application of stratifin and acetylsalicylic acid (ASA) in a rabbit ear model. A total of five New Zealand white rabbits with four wounds per ear were examined. Either recombinant stratifin (0.002%) or ASA (0.5%) incorporated in carboxymethyl cellulose gel was topically applied on each wound at postwounding Day 5. Scars were harvested at postwounding Day 28 for histological analysis. The wounds treated with stratifin and ASA showed 82 and 73% reduction in scar volume, respectively, compared with that of untreated controls. A reduction of 57 and 41% in total tissue cellularity along with 79 and 91% reduction in infiltrated CD3+ T cells were observed in response to treatment with stratifin and ASA, respectively, compared with those of untreated controls. Wounds treated with stratifin showed a 2.8-fold increase in matrix metalloproteinase-1 expression, which resulted in a 48% decrease in collagen density compared with those of untreated controls. Qualitative wound assessment showed a reduced hypertrophic scarring in stratifin and ASA-treated wounds when compared with the controls. This study showed that topical application of either stratifin or ASA-impregnated carboxymethyl cellulose gel reduced hypertrophic scar formation following dermal injuries in a rabbit ear fibrotic model.